Skip to main content
Other
A Phase 2A Clinical Trial of EPI-743 (Vincerinone™) on Visual Function in Friedreich’s Ataxia Patients with Point Mutations
(2012)
  • Kelly L. Sullivan, Georgia Southern University
Disciplines
Publication Date
2012
Citation Information
Kelly L. Sullivan(Project Manager), "A Phase 2A Clinical Trial of EPI-743 (Vincerinone™) on Visual Function in Friedreich’s Ataxia Patients with Point Mutations," Edison Pharmaceuticals, Inc (Investigator Initiated). (2012-present).